Newsroom
July 30, 2023
Sudha Seshadri, MD, Neurology and founding director, The Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio, was featured in this story. Read More
June 23, 2023
Can the body’s naturally occurring “pot” be boosted in the brain to treat Alzheimer’s disease? A researcher at The University of Texas Health Science Center at San Antonio is studying that intriguing question with $4.4 million in newly awarded funding from the National Institutes of Health. Delta9-tetrahydrocannabinol (THC), derived from marijuana or cannabis plants, […]
June 12, 2023
Clinical trials, brain and biobank donation and risk factors among topics discussed “Think Science: Dementia in South Texas,” a live event moderated by Nathan Cone of Texas Public Radio, drew 300 people to the Joe R. and Teresa Lozano Long Campus June 7 for an intriguing and inspiring discussion of a topic important to so […]
June 12, 2023
Clinical trials, brain and biobank donation and risk factors among topics discussed Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu SAN ANTONIO (June 12, 2023) — “Think Science: Dementia in South Texas,” a live event moderated by Nathan Cone of Texas Public Radio, drew 300 people to the Joe R. and Teresa Lozano Long Campus June 7 for […]
June 7, 2023
Mohamad Habes, PhD, Glenn Biggs Institute/Radiology, was quoted in this article. Read More
May 25, 2023
From social media to ads featuring an earworm jingle, it’s hard to escape hearing about Ozempic. Hailed for its game-changing effect on diabetes and obesity, semaglutide, the generic medication sold under the brand name Ozempic, is now being studied for its effectiveness on another deadly disease — Alzheimer’s. The Glenn Biggs Institute for Alzheimer’s and […]